DSM-Firmenich stock: Kepler Cheuvreux sets EUR 100.00 target for DSM-Firmenich stock

Published on 10/23/2026 at 15:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kepler Cheuvreux's October 6 target is EUR 100.00. DSM-Firmenich stock costs EUR 109.58 on October 23, 2026, 9.58 percent above that target.

Analyst target and reporting date

Kepler Cheuvreux set a EUR 100.00 target and a Hold rating on October 6, 2026.
DSM-Firmenich reported EUR 4.664 billion in second-quarter 2026 revenue and a 19.5 percent adjusted EBITDA margin.
DSM-Firmenich stock costs EUR 109.58 at Lang & Schwarz on October 23, 2026 at 3:33 p.m. CEST.
The company is scheduled to publish third-quarter 2026 sales on November 4, 2026.

Architektur-Render eines gläsernen Forschungsgebäudes nahe Kaiseraugst — dsm-firmenich AG (ISIN CH1216478797) unterhält einen Forschungsstandort nahe Kaiseraugst, hier als modernes Architektur-Render gezeigt, Illustration mit AI erstellt.

Kepler Cheuvreux set a EUR 100.00 target and a Hold rating for DSM-Firmenich on October 6, 2026, according to Ideal Investisseur. The stock was trading at EUR 109.58 at Lang & Schwarz on October 23, 2026 at 3:33 p.m. CEST, placing it 9.58 percent above that target.

Second-quarter margins set the tone

DSM-Firmenich generated EUR 4.664 billion in revenue in the second quarter of 2026 and reported EUR 212.00 million in net income. The quarterly figures show the scale of the group after its combination of nutrition, health, beauty and fragrance activities.

Management commentary cited 6.00 percent like-for-like growth and a 19.50 percent adjusted EBITDA margin for the second quarter. Those figures were included in the earnings-call transcript published by Yahoo Finance on October 15, 2026.

Stock trades above the target

The EUR 109.58 Lang & Schwarz quote is 9.58 percent above Kepler Cheuvreux's EUR 100.00 target. The analyst page lists four opinions, with one positive view and three neutral views, while its targets span EUR 68.00 to EUR 117.00.

DSM-Firmenich's market capitalization stood at EUR 26.7 billion on October 23, 2026. The quote was also below the EUR 117.00 high end of the published target range, leaving the analyst spread as an important measure of expectations.

November 4 sales date ahead

The next scheduled corporate date is the publication of third-quarter 2026 sales on November 4, 2026, according to Ideal Investisseur. The same calendar lists annual 2026 results for February 18, 2027.

What does the target imply?

Kepler Cheuvreux's target is EUR 9.58 below the Lang & Schwarz quote, a gap of 8.74 percent relative to the stock price. The next sales update will give investors a fresh operating checkpoint after the second-quarter revenue of EUR 4.664 billion.

Stock position and outlook

DSM-Firmenich combines specialty chemicals with nutrition, health and beauty products. Its four operating areas include Perfumery and Beauty, Taste, Texture and Health, Health, Nutrition and Care, and Animal Nutrition and Health.

The stock was trading at EUR 109.58 at Lang & Schwarz on October 23, 2026 at 3:33 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of DSM-Firmenich stock.